ID

31995

Beschreibung

A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01898598 Sponsor: Hoffmann-La Roche Information provided by (Responsible Party): Hoffmann-La Roche Study Director: Clinical Trials Hoffmann-La Roche

Link

https://clinicaltrials.gov/show/NCT01898598

Stichworte

  1. 10.10.18 10.10.18 -
Rechteinhaber

Hoffmann-La Roche

Hochgeladen am

10. Oktober 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Basal Cell Carcinoma NCT01898598

Eligibility Basal Cell Carcinoma NCT01898598

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of non-infected, not recurrent, previously untreated basal cell carcinoma
Beschreibung

Diagnosis of non-infected, not recurrent, previously untreated basal cell carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007117
UMLS CUI [1,2]
C0521118
UMLS CUI [2,1]
C0007117
UMLS CUI [2,2]
C2945760
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C0007117
UMLS CUI [3,2]
C0332155
free of any significant physical abnormalities (e.g., tattoos) at the target basal cell carcinoma site
Beschreibung

No significant physical abnormalities at the target basal cell carcinoma (e.g. tattoos)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007117
UMLS CUI [1,2]
C1704258
UMLS CUI [1,3]
C0449695
UMLS CUI [1,4]
C0332197
willing and able to participate in the study as an outpatient and agreement to make frequent visits to the clinic during the treatment and follow-up periods and to comply with study requirements
Beschreibung

Compliance and willingness for study site attendance

Datentyp

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2,1]
C0600109
UMLS CUI [2,2]
C2825164
UMLS CUI [2,3]
C2827364
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with vismodegib
Beschreibung

Prior treatment with vismodegib

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2987716
UMLS CUI [1,2]
C1514463
known hypersensitivity to any of the study drug excipients
Beschreibung

known hypersensitivity to any of the study drug excipients

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C0015237
any metastatic basal cell carcinoma
Beschreibung

Any metastatic basal cell carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C1304306
any locally advanced basal cell carcinoma considered to be inoperable or to have a medical contraindication to surgery
Beschreibung

Inoperable basal cell carcinoma or contraindication to surgery

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007117
UMLS CUI [1,2]
C0205187
UMLS CUI [2]
C0852649
evidence of clinically significant and unstable diseases or conditions (e.g., cardiovascular, immunosuppressive, hematologic)
Beschreibung

Clinically significant and unstable diseases or conditions (e.g. cardiovascular, immunosuppressive, hematologic)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0443343
UMLS CUI [1,3]
C0750502
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0443343
UMLS CUI [2,3]
C0750502
UMLS CUI [3,1]
C4048329
UMLS CUI [3,2]
C0009488
UMLS CUI [3,3]
C0443343
UMLS CUI [3,4]
C0750502
UMLS CUI [4,1]
C0018939
UMLS CUI [4,2]
C0443343
UMLS CUI [4,3]
C0750502
any dermatological disease at the target basal cell carcinoma site that may cause difficulty with examination
Beschreibung

Any dermatological disease at the target basal cell carcinoma site that may cause difficulty with examination

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0037274
UMLS CUI [1,3]
C0449695
recent, current, or planned participation in another experimental drug study
Beschreibung

Recent, current or planned participation in another experimental drug study

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568

Ähnliche Modelle

Eligibility Basal Cell Carcinoma NCT01898598

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
adult patients, >=18 years of age
boolean
C0001779 (UMLS CUI [1])
Diagnosis of non-infected, not recurrent, previously untreated basal cell carcinoma
Item
diagnosis of non-infected, not recurrent, previously untreated basal cell carcinoma
boolean
C0007117 (UMLS CUI [1,1])
C0521118 (UMLS CUI [1,2])
C0007117 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0007117 (UMLS CUI [3,1])
C0332155 (UMLS CUI [3,2])
No significant physical abnormalities at the target basal cell carcinoma (e.g. tattoos)
Item
free of any significant physical abnormalities (e.g., tattoos) at the target basal cell carcinoma site
boolean
C0007117 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C0449695 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Compliance and willingness for study site attendance
Item
willing and able to participate in the study as an outpatient and agreement to make frequent visits to the clinic during the treatment and follow-up periods and to comply with study requirements
boolean
C1321605 (UMLS CUI [1])
C0600109 (UMLS CUI [2,1])
C2825164 (UMLS CUI [2,2])
C2827364 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Prior treatment with vismodegib
Item
prior treatment with vismodegib
boolean
C2987716 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
known hypersensitivity to any of the study drug excipients
Item
known hypersensitivity to any of the study drug excipients
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0015237 (UMLS CUI [1,3])
Any metastatic basal cell carcinoma
Item
any metastatic basal cell carcinoma
boolean
C1304306 (UMLS CUI [1])
Inoperable basal cell carcinoma or contraindication to surgery
Item
any locally advanced basal cell carcinoma considered to be inoperable or to have a medical contraindication to surgery
boolean
C0007117 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C0852649 (UMLS CUI [2])
Clinically significant and unstable diseases or conditions (e.g. cardiovascular, immunosuppressive, hematologic)
Item
evidence of clinically significant and unstable diseases or conditions (e.g., cardiovascular, immunosuppressive, hematologic)
boolean
C0009488 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C0007222 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0750502 (UMLS CUI [2,3])
C4048329 (UMLS CUI [3,1])
C0009488 (UMLS CUI [3,2])
C0443343 (UMLS CUI [3,3])
C0750502 (UMLS CUI [3,4])
C0018939 (UMLS CUI [4,1])
C0443343 (UMLS CUI [4,2])
C0750502 (UMLS CUI [4,3])
Any dermatological disease at the target basal cell carcinoma site that may cause difficulty with examination
Item
any dermatological disease at the target basal cell carcinoma site that may cause difficulty with examination
boolean
C0009488 (UMLS CUI [1,1])
C0037274 (UMLS CUI [1,2])
C0449695 (UMLS CUI [1,3])
Recent, current or planned participation in another experimental drug study
Item
recent, current, or planned participation in another experimental drug study
boolean
C2348568 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video